LATEST NEWS
December 18, 2020 | Company Announcements
Bavarian Nordic Announces Top-line Results from Phase 2 Clinical Trial of BN-Brachyury in ChordomaDecember 16, 2020 | Company Announcements
Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. GovernmentDecember 08, 2020 | Company Announcements
Bavarian Nordic Introduces New Employee Incentive Program November 16, 2020 | Company Announcements
Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.November 11, 2020 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2020 October 09, 2020 | Company Announcements
Bavarian Nordic Announces Appointment of Anu Helena Kerns as Executive Vice President, People and OrganizationSeptember 02, 2020 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back ProgramAugust 26, 2020 | Company Announcements
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme ObligationsAugust 26, 2020 | Company Announcements
Bavarian Nordic Announces First Half 2020 Results August 24, 2020 | Company Announcements
Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine